Analysts Offer Insights on Healthcare Companies: SAGE Therapeutics (NASDAQ: SAGE) and Revolution Medicines (NASDAQ: RVMD)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on SAGE Therapeutics (SAGE – Research Report) and Revolution Medicines (RVMD – Research Report). SAGE Therapeutics (SAGE) In More »

JonesTrading Keeps Their Buy Rating on Chimerix (CMRX)

In a report released today, Soumit Roy from JonesTrading reiterated a Buy rating on Chimerix (CMRX – Research Report), with a price target of $14.00. The company’s shares closed last Friday at More »